Filter
1296
Text search:
oxygen
Featured
Recommendations
216
New Publications
238
Language
Document type
No document type
532
Guidelines
291
Studies & Reports
175
Manuals
102
Strategic & Response Plan
55
Fact sheets
43
Training Material
36
Situation Updates
23
Infographics
21
Resource Platforms
7
Online Courses
5
Brochures
4
Videos
2
Countries / Regions
India
107
Global
44
Kenya
42
South Africa
41
Ethiopia
31
Rwanda
27
Nepal
26
Syria
25
Nigeria
20
Liberia
18
Latin America and the Carribbean
18
Ukraine
17
Bangladesh
16
Malawi
16
Africa
16
Ghana
15
Uganda
15
Zambia
15
Sierra Leone
14
Tanzania
14
Western and Central Europe
14
Russia
13
Philippines
12
Brazil
12
West and Central Africa
12
Indonesia
11
Namibia
11
Myanmar / Burma
11
East and Southern Africa
11
South–East Asia Region
9
USA
7
Middle East and North Africa
7
Eastern Europe and Central Asia
7
Senegal
6
Congo, Democratic Republic of
6
South Sudan
5
Mozambique
5
Yemen
5
Burkina Faso
4
Zimbabwe
4
Haiti
4
Iraq
4
Eswatini/ Swaziland
4
Guinea
3
Mali
3
Côte d’Ivoire / Ivory Coast
3
Somalia
3
Germany
3
Papua New Guinea
3
Botswana
3
Moldova
3
Pakistan
2
Afghanistan
2
Turkey
2
Chad
2
Cambodia
2
China
2
Angola
2
Lesotho
2
Western Pacific Region
2
Asia
2
Bhutan
2
Venezuela
2
Eastern Europe
2
Vietnam
2
United Kingdom
2
Guinea-Bissau
1
Saudi Arabia
1
Cameroon
1
Gambia
1
Sudan
1
Benin
1
Argentina
1
North Macedonia
1
Hungary
1
Ecuador
1
Libya
1
Guatemala
1
Other region
1
Paraguay
1
Fiji
1
Solomon Islands
1
Poland
1
Mongolia
1
Congo-Brazzaville
1
Timor Leste/ East Timor
1
Bulgaria
1
Romania
1
Slovakia
1
France
1
Mauritius
1
Portugal
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
542
Clinical Guidelines
190
Women & Child Health
108
Public Health
60
Key Resources
48
Capacity Building
28
Pharmacy & Technologies
21
Protection & Security
1
Toolboxes
COVID-19
310
Caregiver
93
Planetary Health
46
Conflict
42
Mental Health
41
NCDs
41
Pharmacy
40
Rapid Response
38
TB
28
Ebola
26
Specific Hazards
22
NTDs
20
Disability
19
Natural Hazards
19
Global Health Education
16
HIV
13
Refugee
12
AMR
12
Health Financing Toolbox
7
Cholera
6
Zika
2
Polio
1
Social Ethics
1
COVID-19 has altered health sector capacity in low-income and middle-income countries (LMICs). Cost data to inform evidence-based priority setting are urgently needed. Consequently, in this paper, we calculate the full economic health sector costs of COVID-19 clinical management in 79 LMICs under di
...
This results report for the biennium 2020–2021 presents the progress towards the triple billion targets, outcomes and outputs, based on the GPW 13 results framework and indicators. It uses structured methodologies, both quantitative and qualitative, for measuring and analysing the achievements and
...
Six months after its launch on 24 April, the Access to COVID-19 Tools (ACT) Accelerator has already delivered concrete results in speeding up the development of new therapeutics, diagnostics, and vaccines. Now mid-way through the scale-up phase, the tools we need to fundamentally change the course o
...
Development finance institutions owned by European governments and the World Bank Group are spending hundreds of millions of dollars on expensive for-profit hospitals in the Global South that block patients from getting care, or bankrupt them, with some even imprisoning patients who cannot afford th
...
The GFF needs an additional US$2.5 billion from 2021 to 2025 to enable countries to protect health gains and accelerate progress toward the 2030 Goals. Of this amount, the GFF urgently needs to secure new pledges of US$1.2 billion by the end of 2021 to help its current 36 partner countries protect
...
Over the 20 years that followed, this unique partnership has invested more than US$53 billion, saving 44 million lives and reducing the combined death rate from the three diseases by more than half in the countries in which the Global Fund invests.
The WHO COVID-19 Clinical management: living guidance contains the most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important.
Developmental disabilities are common. Yet, children with developmental disabilities have been neglected in health systems planning and policy provisions for health and continue to experience stigmatization, institutionalization, barriers to access health care and inequalities in health and educatio
...
Health facilities in the Region of the Americas frequently suffer the effects of health emergencies and disasters, which jeopardize their ability to provide services to the population. The STAR-H methodology helps staff responsible for health emergency and disaster risk management to identify and as
...
Infection prevention and control (IPC) in a CTC/ CTU IPC are all practical measures taken in the healthcare facility to prevent harm caused by infections to patients, health workers and communities.
The main goal of IPC in the cholera response is to
• To reduce transmission of health care-as
...
WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines.
Updated risk rates for hospital admission in patients with non-severe COVID-19
The guidance includes updated risk rates for
...
This checklist is an operational tool to help national authorities develop or revise national respiratory pathogen (inclusive of influenza and coronaviruses) pandemic preparedness plans.
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm
...
Peripheral artery disease (PAD) is the most underdiagnosed, underestimated and undertreated of the atherosclerotic vascular diseases despite its poor prognosis. There may be racial or contextual differences in the Asia-Pacific region as to epidemiology, availability of diagnostic and therapeutic mod
...
Heart failure with a reduced ejection fraction (HFrEF) is a condition frequently encountered by healthcare professionals and, in order to achieve the best outcomes for patients, needs to be managed optimally. This guideline document is based on the European Society of Cardiology Guidelines for the t
...
Many features of the environment have been found to exert an important influence on cardiovascular disease (CVD) risk, progression, and severity. Changes in the environment due to migration to different geographic locations, modifications in lifestyle choices, and shifts in social policies and cultu
...
Hypertension is referred to as a “silent killer”. Most people with hypertension are unaware of their condition as in most cases, they experience no warning signs or symptoms hence they are not identified or treated. Hypertention is associated with a number of conditions, disability, and causes o
...
Atherosclerotic lower-extremity peripheral artery disease (PAD) is increasingly recognized as an important cause of cardiovascular morbidity and mortality that affects more than 230 million people worldwide. Traditional cardiovascular risk factors, including advanced age, smoking, and diabetes, are
...
In 2024, we need US$1.5 billion to provide live-saving health care to millions of people in emergencies. An alarming combination of conflict, climate-related threats and increasing economic hardship mean an estimated 166 million people require health assistance.
In this version of the compendium, each guidance is coded using the International Classification of Health Interventions (ICHI).
The compendium provides a systematic compilation of published guidance from WHO and other UN organizations on health and environment. Guidance on policies and actions a
...
